22.06.2020 APEPTICO has been nominated one of the most innovative companies in Austria in the categories medicines and organic chemistrymore
22.06.2020 HOOKIPA Announces Positive Phase 2 Interim Safety and Immunogenicity Results for its CMV Vaccine Candidate HB 101more
22.06.2020 ETIHAD AIRWAYS PARTNERS WITH MEDICUS AI TO LAUNCH COVID-19 RISK ASSESSMENT TOOL ACROSS DIGITAL PLATFORMSmore
19.06.2020 The Lancet Neurology publishes positive results of AFFiRiS’ Phase 1 trial with PD01A in Parkinson’s disease patientsmore
19.06.2020 CeMM receives the special prize of the Austrian “Innovation Awards 2020/2021” in organic chemistrymore
19.06.2020 HOOKIPA Announces Changes to its Board of Directors – Resignation of Sander van Deventermore
18.06.2020 HOOKIPA Announces FDA Clearance of its IND Application for HB-202/201 Clinical Trial to Treat HPV-Positive Cancersmore
17.06.2020 CALYXHA seeking EUR 5m in Series A funding by mid-2021; aims to lock in several global partnerships for tissue degeneration product, says CEOmore
16.06.2020 F2G’s olorofim receives both FDA Orphan Drug Designation for Coccidioidomycosis (Valley Fever) and FDA QIDP designation for multiple fungal infectionsmore
16.06.2020 SARS-CoV-2 und das Immunsystem: Wie sich COVID-19 in der 3D-Zellkultur simulieren lässtmore
12.06.2020 DSM wächst mit der Akquisition der Erber Group, einem weltweit führenden Unternehmen im Bereich Tierernährung und Tiergesundheitmore